Carta científico-clínica
Respuesta a secukinumab tras fracaso terapéutico con ustekinumab en seis pacientes con psoriasis en placas
Response to Secukinumab after Treatment Failure with Ustekinumab in 6 Patients with Plaque Psoriasis
D. Morgado-Carrasco, J. Riera-Monroig, X. Fustà-Novell, M. Alsina Gibert
Autor para correspondencia
Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, España
Leído
6407
Vecesse ha leído el artículo
2141
Total PDF
4266
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 7 | 5 | 1 | 6 |
| 2025 6 | 129 | 13 | 142 |
| 2025 5 | 104 | 26 | 130 |
| 2025 4 | 119 | 21 | 140 |
| 2025 3 | 101 | 19 | 120 |
| 2025 2 | 101 | 39 | 140 |
| 2025 1 | 81 | 35 | 116 |
| 2024 12 | 90 | 21 | 111 |
| 2024 11 | 112 | 60 | 172 |
| 2024 10 | 81 | 42 | 123 |
| 2024 9 | 81 | 20 | 101 |
| 2024 8 | 98 | 43 | 141 |
| 2024 7 | 106 | 24 | 130 |
| 2024 6 | 105 | 43 | 148 |
| 2024 5 | 81 | 26 | 107 |
| 2024 4 | 103 | 24 | 127 |
| 2024 3 | 77 | 31 | 108 |
| 2024 2 | 76 | 23 | 99 |
| 2024 1 | 83 | 26 | 109 |
| 2023 12 | 60 | 15 | 75 |
| 2023 11 | 104 | 29 | 133 |
| 2023 10 | 89 | 36 | 125 |
| 2023 9 | 87 | 30 | 117 |
| 2023 8 | 62 | 15 | 77 |
| 2023 7 | 89 | 45 | 134 |
| 2023 6 | 74 | 26 | 100 |
| 2023 5 | 73 | 25 | 98 |
| 2023 4 | 54 | 20 | 74 |
| 2023 3 | 77 | 27 | 104 |
| 2023 2 | 53 | 24 | 77 |
| 2022 1 | 41 | 27 | 68 |
| 2022 12 | 60 | 39 | 99 |
| 2022 11 | 97 | 40 | 137 |
| 2022 10 | 88 | 53 | 141 |
| 2022 9 | 67 | 54 | 121 |
| 2022 8 | 64 | 60 | 124 |
| 2022 7 | 51 | 62 | 113 |
| 2022 6 | 49 | 47 | 96 |
| 2022 5 | 37 | 37 | 74 |
| 2022 4 | 41 | 28 | 69 |
| 2022 3 | 60 | 58 | 118 |
| 2022 2 | 44 | 33 | 77 |
| 2021 1 | 37 | 37 | 74 |
| 2021 12 | 39 | 31 | 70 |
| 2021 11 | 40 | 34 | 74 |
| 2021 10 | 73 | 51 | 124 |
| 2021 9 | 38 | 36 | 74 |
| 2021 8 | 28 | 25 | 53 |
| 2021 7 | 40 | 34 | 74 |
| 2021 6 | 60 | 33 | 93 |
| 2021 5 | 46 | 43 | 89 |
| 2021 4 | 86 | 76 | 162 |
| 2021 3 | 54 | 27 | 81 |
| 2021 2 | 53 | 23 | 76 |
| 2020 1 | 29 | 22 | 51 |
| 2020 12 | 44 | 21 | 65 |
| 2020 11 | 35 | 27 | 62 |
| 2020 10 | 24 | 24 | 48 |
| 2020 9 | 33 | 18 | 51 |
| 2020 8 | 47 | 28 | 75 |
| 2020 7 | 39 | 21 | 60 |
| 2020 6 | 41 | 41 | 82 |
| 2020 5 | 28 | 29 | 57 |
| 2020 4 | 28 | 24 | 52 |
| 2020 3 | 25 | 25 | 50 |
| 2020 2 | 2 | 4 | 6 |
| 2019 12 | 1 | 1 | 2 |
| 2019 11 | 19 | 0 | 19 |
| 2019 10 | 1 | 0 | 1 |
| 2019 9 | 1 | 0 | 1 |
| 2019 5 | 1 | 1 | 2 |
| 2019 4 | 2 | 2 | 4 |
| 2019 3 | 1 | 2 | 3 |
| 2019 2 | 1 | 0 | 1 |
| 2018 12 | 6 | 8 | 14 |
| 2018 11 | 3 | 2 | 5 |
| 2018 9 | 2 | 3 | 5 |
| 2018 8 | 5 | 4 | 9 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 0 | 2 | 2 |
| 2018 3 | 0 | 1 | 1 |
| 2018 2 | 0 | 2 | 2 |
| 2018 1 | 0 | 9 | 9 |
| 2017 12 | 0 | 2 | 2 |
Mostrar todo
